Showing results (81-90 of 311) with videos related to
Sort By:
Pageof 32
British Journal of Cancer|November 1, 1985
Pharmacokinetics, binding and distribution of Hoechst 33342 in spheroids and murine tumoursP L Olive, D J Chaplin, R E DurandBritish Journal of Cancer|March 10, 2001
Proportion of infiltrating IgG-binding immune cells predict for tumour hypoxiaD R Collingridge, S A Hill, D J ChaplinAnticancer Research|January 11, 2000
Tumor blood flow modifying effect of electrochemotherapy with bleomycinG Sersa, M Cemazar, D Miklavcic, et al.International Journal of Cancer|September 27, 1995
Anti-vascular approaches to solid tumour therapy: evaluation of vinblastine and flavone acetic acidS A Hill, L E Sampson, D J ChaplinGynecologic Oncology|February 28, 2017
The development and use of vascular targeted therapy in ovarian cancerDana M Chase, David J Chaplin, Bradley J MonkInternational Journal of Radiation Oncology, Biology, Physics|August 1, 1986
Acute hypoxia in tumors: implications for modifiers of radiation effectsD J Chaplin, R E Durand, P L OliveVeterinary Research|August 5, 1998
Ovine cytokines and their role in the immune responseJ P Scheerlinck, P J Chaplin, P R WoodCancer|June 16, 2004
Vascular-targeting therapies for treatment of malignant diseaseDietmar W Siemann, David J Chaplin, Michael R HorsmanCurrent Opinion in Investigational Drugs (London, England : 2000)|June 21, 2006
Current development status of small-molecule vascular disrupting agentsDavid J Chaplin, Michael R Horsman, Dietmar W SiemannBritish Journal of Cancer|December 1, 1990
Effect of vascular marker Hoechst 33342 on tumour perfusion and cardiovascular function in the mouseM J Trotter, P L Olive, D J ChaplinPageof 32